 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- Lu AG06479 / Lundbeck
Enrollment change, Trial termination: Safety and Tolerability of Lu AG06479 in Healthy Young Men (clinicaltrials.gov) - Dec 14, 2021
P1, N=46, Terminated, Sponsor: H. Lundbeck A/S
N=66 --> 46 | Recruiting --> Terminated; The study was terminated for strategic reasons.
- || Lu AG06479 / Lundbeck
Trial completion date, Trial primary completion date: Safety and Tolerability of Lu AG06479 in Healthy Young Men (clinicaltrials.gov) - Sep 27, 2021
P1, N=66, Recruiting, Sponsor: H. Lundbeck A/S
N=66 --> 46 | Recruiting --> Terminated; The study was terminated for strategic reasons. Trial completion date: Apr 2021 --> Jan 2022 | Trial primary completion date: Apr 2021 --> Jan 2022
- ||| Lu AG06479 / Lundbeck
New P1 trial: Safety and Tolerability of Lu AG06479 in Healthy Young Men (clinicaltrials.gov) - Jul 16, 2020
P1, N=66, Recruiting, Sponsor: H. Lundbeck A/S